Primary central nervous system lymphoma: Difference between revisions
No edit summary |
|||
Line 33: | Line 33: | ||
==Diagnosis== | ==Diagnosis== | ||
[[Primary central nervous system lymphoma history and symptoms|History and Symptoms ]] | [[ Primary central nervous system lymphoma physical examination|Physical Examination]] | [[Primary central nervous system lymphoma laboratory | [[Primary central nervous system lymphoma history and symptoms|History and Symptoms ]] | [[ Primary central nervous system lymphoma physical examination|Physical Examination]] | [[Primary central nervous system lymphoma laboratory tests|Laboratory Findings]] | [[Primary central nervous system lymphoma CT|CT]] | [[Primary central nervous system lymphoma MRI|MRI]] | [[Primary central nervous system lymphoma other imaging findings|Other Imaging Findings]] | [[Primary central nervous system lymphoma other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== |
Revision as of 06:49, 17 September 2012
Template:DiseaseDisorder infobox
Primary central nervous system lymphoma Microchapters |
Differentiating Primary Central Nervous System Lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Primary central nervous system lymphoma On the Web |
American Roentgen Ray Society Images of Primary central nervous system lymphoma |
Directions to Hospitals Treating Primary central nervous system lymphoma |
Risk calculators and risk factors for Primary central nervous system lymphoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
For patient information click here
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Primary central nervous system lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies